Yumanity Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Kineta

20/05/2021 20:50

* Yumanity Therapeutics Inc  YMTX.OQ  reported a quarterly
adjusted loss of 85 cents​​ per share for the quarter ended
in March. The mean expectation of two analysts for the quarter
was for a loss of 83 cents per share.
* Revenue was $3.53 million​;  analysts expected $2.27 million. 
* Yumanity Therapeutics Inc's reported EPS for the quarter was a
loss of 85 cents​.
* The mean earnings estimate of analysts had risen by about 4.6%
in the last three months.​ 
* In the last 30 days there have been no negative revisions of
earnings estimates 
* Yumanity Therapeutics Inc shares had fallen by 23.5% this
quarter and lost 18.6% so far this year.
* The company reported a quarterly loss of $8.68 million.
* Wall Street's median 12-month price target for Yumanity
Therapeutics Inc is $36.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated May 20 at 07:50 p.m. GMT.
​All figures in US dollars